1700P Impact of sarcomatoid (S) and rhabdoid (R) components (comp.) on the efficacy of nivolumab (N) +/- ipilimumab (I) in the first-line (L1) treatment of metastatic clear cell renal cell carcinoma (mRCC) in the randomized phase II BIONIKK trial
| Autor: | Vano, Y-A., Hernandez, I., Bennamoun, M., Verkarre, V., Chevreau, C.M., Gross Goupil, M., Tournigand, C., Borchiellini, D., Laguerre, B., Maillet, D., Barthelemy, P., Gravis, G., Coquan, E., Pannier, D., Houede, N., Kotti, S., Fridman, W-H., Sautes-Fridman, C., Sun, C-M., Oudard, S. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S1019-S1019 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|